Oak Street Health (NYSE:OSH) PT Raised to $32.00

Oak Street Health (NYSE:OSHGet Rating) had its price objective boosted by analysts at SVB Leerink from $23.00 to $32.00 in a research report issued on Thursday, MarketBeat reports. The brokerage currently has a “market perform” rating on the stock. SVB Leerink’s price target would suggest a potential upside of 5.65% from the stock’s previous close.

OSH has been the topic of several other reports. UBS Group increased their target price on Oak Street Health from $26.00 to $28.00 and gave the stock a “neutral” rating in a research report on Wednesday. Stifel Nicolaus raised their price objective on Oak Street Health from $25.00 to $35.00 in a research report on Wednesday, July 27th. Sanford C. Bernstein assumed coverage on Oak Street Health in a research report on Thursday, May 26th. They issued an “outperform” rating and a $26.00 price objective on the stock. Barclays raised their price objective on Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research report on Tuesday, April 19th. Finally, Argus assumed coverage on Oak Street Health in a research report on Tuesday, July 26th. They issued a “hold” rating on the stock. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $35.50.

Oak Street Health Stock Up 2.4 %

Shares of OSH opened at $30.29 on Thursday. The company has a quick ratio of 1.79, a current ratio of 1.57 and a debt-to-equity ratio of 16.10. The stock’s fifty day simple moving average is $21.54 and its 200 day simple moving average is $20.69. Oak Street Health has a twelve month low of $13.29 and a twelve month high of $64.75.

Oak Street Health (NYSE:OSHGet Rating) last issued its earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.04). The firm had revenue of $513.80 million during the quarter, compared to analysts’ expectations of $506.82 million. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 27.11%. The company’s quarterly revenue was up 73.2% compared to the same quarter last year. During the same period last year, the business posted ($0.29) earnings per share. Equities research analysts expect that Oak Street Health will post -2.24 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Michael T. Pykosz sold 157,534 shares of Oak Street Health stock in a transaction dated Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total value of $4,730,746.02. Following the completion of the transaction, the chief executive officer now directly owns 7,189,050 shares in the company, valued at $215,887,171.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Oak Street Health news, insider Geoffrey M. Price sold 147,511 shares of Oak Street Health stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $30.03, for a total value of $4,429,755.33. Following the completion of the transaction, the insider now directly owns 1,395,759 shares in the company, valued at $41,914,642.77. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael T. Pykosz sold 157,534 shares of Oak Street Health stock in a transaction that occurred on Tuesday, August 2nd. The shares were sold at an average price of $30.03, for a total value of $4,730,746.02. Following the completion of the transaction, the chief executive officer now owns 7,189,050 shares of the company’s stock, valued at $215,887,171.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,014,413 shares of company stock worth $25,854,151. Corporate insiders own 11.40% of the company’s stock.

Hedge Funds Weigh In On Oak Street Health

A number of hedge funds and other institutional investors have recently bought and sold shares of OSH. State of New Jersey Common Pension Fund D boosted its stake in Oak Street Health by 23.7% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 77,309 shares of the company’s stock valued at $2,562,000 after acquiring an additional 14,799 shares during the period. CWM LLC bought a new stake in shares of Oak Street Health during the fourth quarter valued at approximately $851,000. C WorldWide Group Holding A S raised its holdings in shares of Oak Street Health by 8.0% during the fourth quarter. C WorldWide Group Holding A S now owns 404,933 shares of the company’s stock valued at $13,419,000 after buying an additional 30,000 shares during the last quarter. Toronto Dominion Bank raised its holdings in shares of Oak Street Health by 39.6% during the fourth quarter. Toronto Dominion Bank now owns 18,999 shares of the company’s stock valued at $629,000 after buying an additional 5,393 shares during the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its holdings in shares of Oak Street Health by 32.4% during the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 27,078 shares of the company’s stock valued at $934,000 after buying an additional 6,630 shares during the last quarter. 91.42% of the stock is currently owned by institutional investors and hedge funds.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Featured Stories

Analyst Recommendations for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.